Analyst Ratings for Theravance Biopharma (TBPH)
TBPH Rating Summary
TBPH Price Target Summary
- Highest: $17.00 (B.Riley)
- Lowest: $15.00 (TD Cowen)
- Average: $16.00
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$16.00 (-6%)
* Over Last 12-Mos
Rating Score: 2.4 / 10
Percentile Rank: 18%
Avg. $ Target:
$16.00 (-6%)
* Over Last 12-Mos
Rating Score: 2.4 / 10
Percentile Rank: 18%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/7/2026 | H.C. Wainwright | Douglas Tsao | Downgrade | Neutral (Buy) |
N/A (N/A) |
17.00 (17.03) |
0.18% | Details |
| 6/29/2026 | BTIG | Julian Harrison | Downgrade | Neutral (Buy) |
N/A (N/A) |
17.63 (17.03) |
-3.4% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
